Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell 1

Interventions

Rituximab 1402 Cyclophosphamide 1308 Vincristine 670 Doxorubicin 589 Etoposide 527 Prednisone 512 Cytarabine 487 fludarabine 470 Methotrexate 446 Dexamethasone 414 fludarabine phosphate 400 Lenalidomide 356 Filgrastim 343 Bendamustine Hydrochloride 283 Radiotherapy 267 venetoclax 261 ibrutinib 258 obinutuzumab 236 Peripheral Blood Stem Cell Transplantation 234 Melphalan 230 Granulocyte Colony-Stimulating Factor 215 Bortezomib 204 Gemcitabine 202 Busulfan 188 Whole-Body Irradiation 187 Mycophenolic Acid 175 Tacrolimus 165 Specimen Handling 164 Magnetic Resonance Spectroscopy 157 Calcium Dobesilate 151

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Flavin-Adenine Dinucleotide × Lymphoid × Clear all

NCT00840385 2010-09-15

FAD

Fudan University

Phase 2 Unknown

Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon ⚡